Clinical Trial Update: Evaluating the Impact of Single Dose Tiotropium on Allergen-induced Early Asthmatic Response [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating the impact of a single dose tiotropium on the early allergen-induced asthmatic response; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• tiotropium (tiotropium)

Snippet

Sponsor: University of Saskatchewan | Conditions: Asthma Bronchiale | Phase 4 | Status: NOT_YET_RECRUITING